Which has higher valuation and earnings, HTFL or PHR?

Phreesia has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 14.38 -$116.79M -$3.11 N/A Phreesia $480.59M 1.60 $2.31M $0.15 82.93

Is HTFL or PHR more profitable?

Phreesia has a net margin of 1.85% compared to Heartflow's net margin of -58.42%. Phreesia's return on equity of 5.13% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% Phreesia 1.85% 5.13% 3.12%

Does the media favor HTFL or PHR?

In the previous week, Phreesia had 2 more articles in the media than Heartflow. MarketBeat recorded 3 mentions for Phreesia and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Phreesia's score of 0.35 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Phreesia 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, PHR or CERT?

Phreesia has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.60 $2.31M $0.15 82.93 Certara $418.84M 2.94 -$1.60M -$0.45 N/A

Is PHR or CERT more profitable?

Phreesia has a net margin of 1.85% compared to Certara's net margin of -16.75%. Phreesia's return on equity of 5.13% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Phreesia 1.85% 5.13% 3.12% Certara -16.75% 3.86% 2.65%

Does the media favor PHR or CERT?

In the previous week, Certara had 21 more articles in the media than Phreesia. MarketBeat recorded 24 mentions for Certara and 3 mentions for Phreesia. Certara's average media sentiment score of 0.61 beat Phreesia's score of 0.35 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Certara 11 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PHR or TDOC?

In the previous week, Teladoc Health had 13 more articles in the media than Phreesia. MarketBeat recorded 16 mentions for Teladoc Health and 3 mentions for Phreesia. Phreesia's average media sentiment score of 0.35 beat Teladoc Health's score of 0.17 indicating that Phreesia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Teladoc Health 2 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral

Which has better earnings and valuation, PHR or SDGR?

Phreesia has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.60 $2.31M $0.15 82.93 Schrodinger $255.87M 5.42 -$103.26M -$0.74 N/A

Is PHR or SDGR more profitable?

Phreesia has a net margin of 1.85% compared to Schrodinger's net margin of -20.98%. Phreesia's return on equity of 5.13% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Phreesia 1.85% 5.13% 3.12% Schrodinger -20.98% -16.37% -8.19%

Does the media refer more to PHR or SDGR?

In the previous week, Schrodinger had 12 more articles in the media than Phreesia. MarketBeat recorded 15 mentions for Schrodinger and 3 mentions for Phreesia. Schrodinger's average media sentiment score of 0.57 beat Phreesia's score of 0.35 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 3 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, GDRX or PHR?

GoodRx has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.57 $30.44M $0.04 91.50 Phreesia $480.59M 1.60 $2.31M $0.15 82.93

Is GDRX or PHR more profitable?

GoodRx has a net margin of 2.07% compared to Phreesia's net margin of 1.85%. GoodRx's return on equity of 7.22% beat Phreesia's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Phreesia 1.85% 5.13% 3.12%

Does the media prefer GDRX or PHR?

In the previous week, GoodRx had 10 more articles in the media than Phreesia. MarketBeat recorded 13 mentions for GoodRx and 3 mentions for Phreesia. GoodRx's average media sentiment score of 0.77 beat Phreesia's score of 0.35 indicating that GoodRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Phreesia 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Phreesia (PHR) Competitors

$12.44 -0.07 (-0.56%)

As of 03:58 PM Eastern

Compare

PHR vs. HTFL, CERT, TDOC, SDGR, and GDRX

Should you buy Phreesia stock or one of its competitors? MarketBeat compares Phreesia with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Phreesia include Heartflow (HTFL), Certara (CERT), Teladoc Health (TDOC), Schrodinger (SDGR), and GoodRx (GDRX). These companies are all part of the "healthcare technology" industry.

How does Phreesia compare to Heartflow?

Heartflow (NASDAQ:HTFL) and Phreesia (NYSE:PHR) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

92.1% of Phreesia shares are held by institutional investors. 7.7% of Heartflow shares are held by insiders. Comparatively, 5.2% of Phreesia shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Phreesia has a net margin of 1.85% compared to Heartflow's net margin of -58.42%. Phreesia's return on equity of 5.13% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
Phreesia	1.85%	5.13%	3.12%

Phreesia has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	14.38	-$116.79M	-$3.11	N/A
Phreesia	$480.59M	1.60	$2.31M	$0.15	82.93

Heartflow presently has a consensus price target of $36.57, suggesting a potential upside of 24.60%. Phreesia has a consensus price target of $16.65, suggesting a potential upside of 33.82%. Given Phreesia's higher probable upside, analysts clearly believe Phreesia is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42

In the previous week, Phreesia had 2 more articles in the media than Heartflow. MarketBeat recorded 3 mentions for Phreesia and 1 mentions for Heartflow. Heartflow's average media sentiment score of 0.94 beat Phreesia's score of 0.35 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Phreesia	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Phreesia beats Heartflow on 11 of the 16 factors compared between the two stocks.

How does Phreesia compare to Certara?

Phreesia (NYSE:PHR) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

In the previous week, Certara had 21 more articles in the media than Phreesia. MarketBeat recorded 24 mentions for Certara and 3 mentions for Phreesia. Certara's average media sentiment score of 0.61 beat Phreesia's score of 0.35 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Certara	11 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Phreesia currently has a consensus price target of $16.65, indicating a potential upside of 33.82%. Certara has a consensus price target of $8.28, indicating a potential upside of 2.57%. Given Phreesia's stronger consensus rating and higher possible upside, analysts clearly believe Phreesia is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Phreesia has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market. Comparatively, Certara has a beta of 1.44, meaning that its share price is 44% more volatile than the broader market.

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 5.2% of Phreesia shares are owned by insiders. Comparatively, 1.1% of Certara shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Phreesia has a net margin of 1.85% compared to Certara's net margin of -16.75%. Phreesia's return on equity of 5.13% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
Certara	-16.75%	3.86%	2.65%

Phreesia has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.60	$2.31M	$0.15	82.93
Certara	$418.84M	2.94	-$1.60M	-$0.45	N/A

Summary

Phreesia beats Certara on 12 of the 17 factors compared between the two stocks.

How does Phreesia compare to Teladoc Health?

Phreesia (NYSE:PHR) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Phreesia has a net margin of 1.85% compared to Teladoc Health's net margin of -7.13%. Phreesia's return on equity of 5.13% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
Teladoc Health	-7.13%	-12.15%	-5.83%

92.1% of Phreesia shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 5.2% of Phreesia shares are held by insiders. Comparatively, 0.7% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Phreesia has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.60	$2.31M	$0.15	82.93
Teladoc Health	$2.53B	0.51	-$200.32M	-$0.99	N/A

Phreesia has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, indicating that its stock price is 112% more volatile than the broader market.

Phreesia presently has a consensus target price of $16.65, suggesting a potential upside of 33.82%. Teladoc Health has a consensus target price of $7.54, suggesting a potential upside of 6.14%. Given Phreesia's stronger consensus rating and higher possible upside, equities analysts clearly believe Phreesia is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Teladoc Health had 13 more articles in the media than Phreesia. MarketBeat recorded 16 mentions for Teladoc Health and 3 mentions for Phreesia. Phreesia's average media sentiment score of 0.35 beat Teladoc Health's score of 0.17 indicating that Phreesia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teladoc Health	2 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Phreesia beats Teladoc Health on 13 of the 16 factors compared between the two stocks.

How does Phreesia compare to Schrodinger?

Phreesia (NYSE:PHR) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Phreesia has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.60	$2.31M	$0.15	82.93
Schrodinger	$255.87M	5.42	-$103.26M	-$0.74	N/A

In the previous week, Schrodinger had 12 more articles in the media than Phreesia. MarketBeat recorded 15 mentions for Schrodinger and 3 mentions for Phreesia. Schrodinger's average media sentiment score of 0.57 beat Phreesia's score of 0.35 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	3 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Phreesia has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Schrodinger has a beta of 1.63, indicating that its stock price is 63% more volatile than the broader market.

Phreesia currently has a consensus price target of $16.65, suggesting a potential upside of 33.82%. Schrodinger has a consensus price target of $20.25, suggesting a potential upside of 7.88%. Given Phreesia's stronger consensus rating and higher probable upside, equities research analysts plainly believe Phreesia is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33

Phreesia has a net margin of 1.85% compared to Schrodinger's net margin of -20.98%. Phreesia's return on equity of 5.13% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
Schrodinger	-20.98%	-16.37%	-8.19%

92.1% of Phreesia shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 5.2% of Phreesia shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Phreesia beats Schrodinger on 11 of the 16 factors compared between the two stocks.

How does Phreesia compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Phreesia (NYSE:PHR) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

GoodRx currently has a consensus target price of $4.15, indicating a potential upside of 13.27%. Phreesia has a consensus target price of $16.65, indicating a potential upside of 33.82%. Given Phreesia's stronger consensus rating and higher probable upside, analysts plainly believe Phreesia is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	7 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.07
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42

63.8% of GoodRx shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 5.9% of GoodRx shares are held by company insiders. Comparatively, 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, GoodRx had 10 more articles in the media than Phreesia. MarketBeat recorded 13 mentions for GoodRx and 3 mentions for Phreesia. GoodRx's average media sentiment score of 0.77 beat Phreesia's score of 0.35 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Phreesia	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

GoodRx has a net margin of 2.07% compared to Phreesia's net margin of 1.85%. GoodRx's return on equity of 7.22% beat Phreesia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Phreesia	1.85%	5.13%	3.12%

GoodRx has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market. Comparatively, Phreesia has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

GoodRx has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.57	$30.44M	$0.04	91.50
Phreesia	$480.59M	1.60	$2.31M	$0.15	82.93

Summary

GoodRx beats Phreesia on 9 of the 16 factors compared between the two stocks.

Get Phreesia News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PHR vs. The Competition

Export

Metric	Phreesia	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$768.92M	$1.53B	$7.05B	$24.20B
Dividend Yield	N/A	4.71%	2.58%	3.69%
P/E Ratio	82.93	23.86	269.76	29.11
Price / Sales	1.60	72.44	651.81	13.88
Price / Cash	16.76	30.51	28.89	19.37
Price / Book	2.23	5.34	11.28	4.91
Net Income	$2.31M	-$25.90M	$3.45B	$1.06B
7 Day Performance	10.03%	7.28%	3.61%	1.30%
1 Month Performance	16.64%	3.08%	-0.53%	2.31%
1 Year Performance	-53.93%	-16.16%	77.55%	20.02%

Phreesia Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PHR Phreesia	3.8754 of 5 stars	$12.44 -0.6%	$16.65 +33.8%	-53.7%	$768.92M	$480.59M	82.93	1,789
HTFL Heartflow	3.1731 of 5 stars	$26.76 +6.1%	$36.57 +36.7%	N/A	$2.18B	$176.03M	N/A	699	Analyst Upgrade Gap Down
CERT Certara	2.2557 of 5 stars	$8.18 +1.0%	$8.85 +8.2%	-25.0%	$1.26B	$418.84M	N/A	1,576	Earnings Report
TDOC Teladoc Health	1.6751 of 5 stars	$6.66 -0.8%	$7.54 +13.2%	+2.1%	$1.22B	$2.53B	N/A	5,600
SDGR Schrodinger	1.4788 of 5 stars	$15.28 +0.9%	$20.25 +32.5%	-5.5%	$1.12B	$255.87M	N/A	790	Earnings Report Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PHR) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Phreesia (PHR) Competitors